532039 logo

Zenotech Laboratories Limited Stock Price

BSE:532039 Community·₹2.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

532039 Share Price Performance

₹0
-60.40 (-100.00%)
₹0
-60.40 (-100.00%)
Price ₹0

532039 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks
0 Rewards

Zenotech Laboratories Limited Key Details

₹419.3m

Revenue

₹39.1m

Cost of Revenue

₹380.2m

Gross Profit

₹346.6m

Other Expenses

₹33.6m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
0.55
90.67%
8.02%
0%
View Full Analysis

About 532039

Founded
1989
Employees
228
CEO
Sachin Gavandare
WebsiteView website
zenotechlab.com

Zenotech Laboratories Limited manufactures and markets pharmaceutical specialty generic injectables in the oncology and anesthesiology markets in India. It offers contract manufacturing services for parenteral depot formulations, ophthalmic, oncology oral and injectables, and general injectables. The company also leases out its biotech facility and equipment. In addition, it provides granulocyte-colony stimulating factor and granulocyte-macrophage colony-stimulating factor products. Zenotech Laboratories Limited was incorporated in 1989 and is based in Hyderabad, India.

Recent 532039 News & Updates

Recent updates

No updates